ROHSTOFF INTERNATIONAL

15:00 | 08.11.2017
Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in Healthcare

Illumina, Inc. (NASDAQ: ILMN) announced today that Gary S. Guthart will
join the company’s Board of Directors on December 1, 2017. Dr. Guthart
is President and Chief Executive Officer of Intuitive Surgical, a global
leader in the field of robotic-assisted minimally invasive surgery.

This press release features multimedia. View the full release here:
http://www.businesswire.com/news/home/20171108005548/en/
Gary Guthart (Photo: Business Wire)
Dr. Guthart joined Intuitive Surgical in April 1996 and has served as
the Chief Executive Officer since January 2010. In July 2007, he was
promoted to President, having assumed the role of Chief Operating
Officer in February 2006. Prior to joining Intuitive Surgical, he was
part of the core team developing the foundational technology for
computer-enhanced surgery at SRI International (formerly Stanford
Research Institute). Dr. Guthart served as a member of the Board of
Directors of Affymetrix, Inc. from May 2009 until its acquisition by
Thermo Fisher Scientific Inc. in March 2016.

“Gary is a talented leader who adds a tremendous breadth of industry
knowledge and experience to our exceptional board of directors,” said
Francis deSouza, Illumina President and Chief Executive Officer. “He
will bring leadership, strategy and policy expertise in the healthcare
sector as Illumina continues to drive adoption of genomics in clinical
markets.”

Dr. Guthart received a B.S. in Engineering from the University of
California, Berkeley and an M.S. and a Ph.D. in Engineering Science from
the California Institute of Technology.
About Illumina
Illumina is improving human health by unlocking the power of the genome.
Our focus on innovation has established us as the global leader in DNA
sequencing and array-based technologies, serving customers in the
research, clinical and applied markets. Our products are used for
applications in the life sciences, oncology, reproductive health,
agriculture, and other emerging segments. To learn more, visit www.illumina.com and
follow @illumina.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171108005548/en/


NEWSLETTER

Abonnieren Sie jetzt unseren
aktuellen Newsletter

WIRTSCHAFTSNACHRICHTEN

08:36 Uhr | 21.11.2017
AKTIE IM FOKUS: ProSiebenSat.1 und ...


08:34 Uhr | 21.11.2017
Uniper lehnt ...


08:31 Uhr | 21.11.2017
WDH: Kochboxenversender Hellofresh ...


08:18 Uhr | 21.11.2017
Zinstief drückt Gewinn der ...


08:12 Uhr | 21.11.2017
Aktien Asien: Börsen durchweg im ...